The Safety and Effectiveness of PEEK Interference Screws in Anterior Cruciate Ligament Reconstruction

Sponsor
Central South University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03342222
Collaborator
Rejoin Hangzhou Martins Medical Equipment Co., Ltd. (Other)
120
1
2
24
5

Study Details

Study Description

Brief Summary

Anterior cruciate ligament (ACL) rupture is one of the most common injuries in sports medicine. ACL reconstructions are usually performed to restore the stability of knee joint and prevent the secondary meniscal and chondral lesions.

120 Subjects with ACL injury were randomly assigned to two groups for ACL reconstruction.Group one: tibial fixation with PEEK Interference Screws (Rejoin Hangzhou Martins Medical Equipment Co., Ltd.);Group two: tibial fixation with Biosure PK interference screw (Smith & Nephew plc). The subjects will be followed by 12 months after surgery for evaluations.Outcome measures included Lysholm score,IKDC, ADT,Lachman.

Condition or Disease Intervention/Treatment Phase
  • Device: Interference Screws
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Multi-center, Randomized, Open, Parallel, Noninferiority Clinical Trial to Evaluate the Safety and Effectiveness of PEEK Interference Screws in Anterior Cruciate Ligament Reconstruction
Actual Study Start Date :
Nov 20, 2017
Anticipated Primary Completion Date :
Nov 20, 2019
Anticipated Study Completion Date :
Nov 20, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: PEEK Interference Screws

PEEK Interference Screws provided by Ruijin Hangzhou Martins Medical Equipment Co., Ltd.

Device: Interference Screws
tibial fixation for ACL reconstruction

Active Comparator: Biosure PK interference screw

Biosure PK interference screw from Smith & Nephew plc.

Device: Interference Screws
tibial fixation for ACL reconstruction

Outcome Measures

Primary Outcome Measures

  1. percentage of patients with Lysholm score more than 70 score [12 month]

Secondary Outcome Measures

  1. Lysholm score [1month; 3month; 6 month; 12 month]

  2. IKDC [1month; 3month; 6 month; 12 month]

  3. Anterior drawer test [1month; 3month; 6 month; 12 month]

  4. Lachman test [1month; 3month; 6 month; 12 month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Voluntarily sign the informed consent form; Between the ages of 18 and 75; Positive ADT and positive Lachman test. Unilateral anterior cruciate ligament is confirmed by MRI (without posterior cruciate ligament injury or reconstruction); Tolerated for anterior cruciate ligament reconstruction surgery; Normal contralateral knee

Exclusion Criteria:
  1. Do not meet the diagnostic criteria of anterior cruciate ligament injury;

  2. With posterior cruciate ligament fracture at the same time;

  3. X-ray showed a significant degeneration of the knee (more than four degrees of cartilage injury);

  4. Knee flexion less than 90 degree;

  5. Abnormal body anatomy;

  6. Pregnant, breast-feeding or subjects who plan to become pregnant;

  7. Serious osteoporosis, malignant tumors;

  8. Allergic to implant materials;

  9. Patients with severe malnutrition who can not tolerate surgery;

  10. Severe coagulopathy, such as hemophilia;

  11. Immunodeficiency diseases, including those requiring long-term use of immunosuppressive agents;

  12. The injured knee has a wide range of skin diseases;

  13. Serious obese patients (BMI> 35);

  14. Patients with severe mental illness can not cooperate with postoperative rehabilitation and patients with severe cardiopulmonary disease can not tolerate surgery;

  15. Ipsilateral lower extremity received surgery within the past year;

  16. Has participated in any other clinical trial in the past three months;

  17. Can not comply with the requirements of the study;

  18. Those who the investigator thinks they are inappropriate.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Xiangya Hospital, Central South University Changsha Hunan China 410008

Sponsors and Collaborators

  • Central South University
  • Rejoin Hangzhou Martins Medical Equipment Co., Ltd.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hongbin Lu, Porfessor, Central South University
ClinicalTrials.gov Identifier:
NCT03342222
Other Study ID Numbers:
  • JMST-01
First Posted:
Nov 14, 2017
Last Update Posted:
Apr 30, 2018
Last Verified:
Apr 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hongbin Lu, Porfessor, Central South University

Study Results

No Results Posted as of Apr 30, 2018